Luciana Muniz Pechmann

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Del Prato, Steven E. Kahn, Imre Pávó et al. · The Lancet · 2021 · 642 citations

Medicine, Pharmacology, Pharmacotherapy +16

Sarcopenia in Type 2 Diabetes Mellitus: A Cross-Sectional Observational Study

Luciana Muniz Pechmann, Thaísa Hoffmann Jonasson, V. S. Canossa et al. · International Journal of Endocrinology · 2020 · 54 citations · Full text

Medicine, Endocrinology, Diabetology +16

Improved glycaemic variability and time in range with dapagliflozin versus gliclazide modified release among adults with type 2 diabetes, evaluated by continuous glucose monitoring: A 12‐week randomized controlled trial

André Gustavo Daher Vianna, Claudio S. Lacerda, Luciana Muniz Pechmann et al. · Diabetes Obesity and Metabolism · 2019 · 26 citations

Medicine, Pharmacology, Pharmacotherapy +17

Vildagliptin has the same safety profile as a sulfonylurea on bone metabolism and bone mineral density in post-menopausal women with type 2 diabetes: a randomized controlled trial

André Gustavo Daher Vianna, Claudio S. Lacerda, Luciana Muniz Pechmann et al. · Diabetology & Metabolic Syndrome · 2017 · 25 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Osteosarcopenia and trabecular bone score in patients with type 2 diabetes mellitus

Luciana Muniz Pechmann, Ricardo Rasmussen Petterle, Carolina Aguiar Moreira et al. · Archives of Endocrinology and Metabolism · 2021 · 24 citations · Full text

Medicine, Endocrinology, Geriatric Medicine +17